First malaria vaccine available in Africa

The first vaccine developed to prevent malaria, which causes the death of more than 200,000 children in Africa every year, has started to be used in Malawi.

After decades of development and testing, the world’s first malaria vaccine will be available in Malawi. The vaccine will also be available in Ghana and Kenya in the coming weeks. Under the initial pilot program, one million children under the age of two are expected to become malaria immunity within the next three years.

250,000 children die each year in Africa due to malaria. This disease is undoubtedly one of the world’s biggest global health problems, and for years scientists have been working to develop an effective vaccine. The RTS,S/AS01 vaccine is currently the most advanced malaria vaccine. Work on this vaccine began in the late 1980s. After detailed and rigorous clinical studies, the final tests were completed a few years ago.

Protection rate 40 percent

It was seen that the vaccine prevented malaria cases by 40 percent. While this is not a huge efficacy rate for a vaccine, it has significant potential to reduce high mortality rates in Africa.

Seth Berkley, CEO of Gavi, an association founded to deliver vaccines to low-income countries, said: “Malaria is one of the biggest causes of child mortality worldwide. More than 200,000 children die each year from this disease. These pilots will show us how this vaccine can play a role in reducing the burden on the world’s poorest countries.” says.

This initial pilot program will continue until 2024. The results will then be analyzed and wider applications in other countries will be discussed. Pharmaceutical company GSK, which developed the vaccine, donated 10 million doses of vaccine for this pilot project.

The application time of this vaccine is actually not ideal. Normally, between the fifth and ninth months of the child, it needs to be applied once a month, for a total of three times. A booster vaccine must be given before the second birthday. It may not always be possible to vaccinate children in poor and rural areas during these time intervals.

Other works in progress

But RTS,S/AS01 is just the first of a malaria vaccine on the horizon. GSK is already working on more effective applications of this vaccine. It is stated that in other projects, great success has been achieved in the first attempts. It was stated that a vaccine that has started to be tested on humans has achieved a success of 100 percent without any side effects.

Source: New Atlas

After decades of development and testing, the world’s first malaria vaccine will be available in Malawi. The vaccine will also be available in Ghana and Kenya in the coming weeks. Under the initial pilot program, one million children under the age of two are expected to become malaria immunity within the next three years. 250,000 children die each year in Africa due to malaria. This disease is undoubtedly one of the world’s biggest global health problems, and for years scientists have been working to develop an effective vaccine. The RTS,S/AS01 vaccine is currently the most advanced malaria vaccine. Work on this vaccine began in the late 1980s. After detailed and rigorous clinical studies, the final tests were completed a few years ago. The success rate of the RTS,S/AS01 vaccine is around 40 percent. It is stated that a new vaccine developed by experts and still in the testing phase has achieved 100 percent success.

Leave a Reply

Your email address will not be published. Required fields are marked *